Matches in Wikidata for { <http://www.wikidata.org/entity/Q64639234> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q64639234 description "clinical trial" @default.
- Q64639234 description "ensayu clínicu" @default.
- Q64639234 description "klinisch onderzoek" @default.
- Q64639234 description "клінічне випробування" @default.
- Q64639234 name "Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)" @default.
- Q64639234 type Item @default.
- Q64639234 label "Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)" @default.
- Q64639234 prefLabel "Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)" @default.
- Q64639234 P1132 Q64639234-8C4A62C6-4A67-44AD-9FC3-E38A539C62ED @default.
- Q64639234 P1476 Q64639234-4F212151-D5AA-4E9D-80B3-84D66F957CEC @default.
- Q64639234 P17 Q64639234-0D59D521-A6F4-4266-A8E7-3E4781A90BBD @default.
- Q64639234 P17 Q64639234-17718127-1652-4226-9B59-DA713B487A61 @default.
- Q64639234 P17 Q64639234-51E755A6-6788-4D56-B95B-8FD119015E91 @default.
- Q64639234 P17 Q64639234-669F6274-4EA7-482B-9BE3-673A6757C2F3 @default.
- Q64639234 P17 Q64639234-C6C72875-EF9E-4BDD-AA26-85976BA1DC81 @default.
- Q64639234 P17 Q64639234-D5523F71-63E3-4489-8C28-F497B73EB7AD @default.
- Q64639234 P17 Q64639234-F31B0756-AF8E-48EC-B354-7156D4026055 @default.
- Q64639234 P17 Q64639234-F3BE8F72-F2F0-4AD1-87FD-0F6A625B8023 @default.
- Q64639234 P2899 Q64639234-6D9F8A93-E8FA-46CD-9F12-E4B8C90840B9 @default.
- Q64639234 P3098 Q64639234-8E77D9DD-C527-4C64-A3E6-0F207F802021 @default.
- Q64639234 P31 Q64639234-2D5C8EC7-5074-4AE3-8824-E90CC2EAB891 @default.
- Q64639234 P580 Q64639234-53B9A58E-8A5E-4D36-95CB-30182C7B5655 @default.
- Q64639234 P582 Q64639234-A5B8C376-C370-4F0C-93C6-EC6C9FF1C249 @default.
- Q64639234 P6099 Q64639234-4A3AB458-626C-4CCF-AC35-78777451A589 @default.
- Q64639234 P8363 Q64639234-F009E8DE-C472-4F1D-9089-340767F5D70E @default.
- Q64639234 P1132 "+314" @default.
- Q64639234 P1476 "A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study to Evaluate the Efficacy and Safety of REGN727/SAR236553 in Patients With Primary Hypercholesterolemia Who Are Intolerant to Statins" @default.
- Q64639234 P17 Q142 @default.
- Q64639234 P17 Q145 @default.
- Q64639234 P17 Q16 @default.
- Q64639234 P17 Q20 @default.
- Q64639234 P17 Q30 @default.
- Q64639234 P17 Q38 @default.
- Q64639234 P17 Q40 @default.
- Q64639234 P17 Q801 @default.
- Q64639234 P2899 "+18" @default.
- Q64639234 P3098 "NCT01709513" @default.
- Q64639234 P31 Q30612 @default.
- Q64639234 P580 "2012-09-01T00:00:00Z" @default.
- Q64639234 P582 "2014-05-01T00:00:00Z" @default.
- Q64639234 P6099 Q42824827 @default.
- Q64639234 P8363 Q78089383 @default.